Company Profile

Fabric Genomics (AKA: Omica Inc )
Profile last edited on: 7/3/19      CAGE: 47TJ5      UEI:

Business Identifier: Global healthcare platform: genomic data analysis focused on hereditary disease and oncology
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1611 Telegraph Avenue Suite 500
Oakland, CA 94612
   (510) 595-0800
Location: Single
Congr. District: 13
County: Alameda

Public Profile

Since March 2017 dba Fabric Genomics, - formerly Omicia, Inc.- the firm has re-branded itself to signal launch of fully-integrated and comprehensive genomic data analysis platform for all NGS testing. The firm is developing scalable and integrated informatics systems to interpret human genome sequences for research and clinical applications -- unlocking individualized medicine by translating data derived from whole-genome sequencing into actionable information for researchers and clinicians. Headquartered in Oakland, CA with offices in the U.K., Seattle, Salt Lake City, and Boston, Omicia was founded by scientists and industry veterans in bioinformatics, genomics and diagnostics. The firm maintains a comprehensive database of information about genetic variations related to health conditions and is pioneering new informatics approaches that enhance the power of predictive and preventive medicine. The firm is pioneering new informatics approaches that power next-gen sequencing applications for clinical testing, translational research, and drug development. Omicia's Opal™ platform integrates genome analysis algorithms and automated clinical annotations, enabling labs to identify and report on disease-causing genes with unprecedented accuracy and efficienc

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NIH $1,752,428
Project Title: Clinical Genome Inference System: Variant Prioritization for Clinical Diagnostics
2010 1 NIH $149,168
Project Title: Disease Annotations for Variants in Personal Genomes
2010 1 NIH $150,686
Project Title: Genetic Hotspots for Disease Risk
2010 2 NIH $950,537
Project Title: System to predict novel genetic disease associations
2010 2 NIH $1,118,937
Project Title: Prototype system for genetic marker information delivery

Key People / Management

  Martin G Reese -- Co-founder, President & Chief Scientific Officer

  Mike A Aicher -- Board of Directors

  Joel S Bader

  Paul Billings -- Chief Medical Officer

  Trish Brown -- Vice President, Clinical Services

  Karen L Eilbeck

  Mahsa Ghafourian -- Development

  Edward Kiruluta -- Co-founder & Chief Technology Officer

  Vaness Sawyer -- Director of Marketing

  Charlene Son Rigby -- Vice President, Products

  John Stuelpnagel -- Co-founder, Board of Directors